Mitobronitol
![]() | |
| Names | |
|---|---|
| Preferred IUPAC name 1,6-Dibromo-1,6-dideoxy-D-mannitol | |
| Systematic IUPAC name 1,6-Dibromohexane-2,3,4,5-tetrol[1] | |
| Identifiers | |
| |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.006.979 |
| EC Number |
|
| KEGG | |
| MeSH | Mitobronitol |
PubChem CID | |
| RTECS number |
|
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C6H12Br2O4 | |
| Molar mass | 307.966 g·mol−1 |
| Appearance | Colourless crystals |
| log P | −0.226 (2RS,3RS,4RS,5RS)-2,3,4,5-tetrol |
| Acidity (pKa) | 12.609 (2RS,3RS,4RS,5RS)-2,3,4,5-tetrol |
| Basicity (pKb) | 1.388 (2RS,3RS,4RS,5RS)-2,3,4,5-tetrol |
| Pharmacology | |
| L01AX01 (WHO) | |
| Related compounds | |
Related compounds | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Mitobronitol (1,6-dibromo-1,6-dideoxy-D-mannitol) is a brominated analog of mannitol. It is an anticancer drug that is also classified as an alkylating agent.[2]
References
- ^ "Mitolactol - Compound Summary". PubChem Compound. USA: National Center for Biotechnology Information. 25 March 2005. Identification. Retrieved 22 June 2012.
- ^ Mitobronitol, The Centre for Cancer Education
